European Automated Breast Ultrasound System Market size is estimated to cross USD 740 million by 2028, according to a latest forecast report by Graphical Research.
According to WHO estimates, countries in Europe have the highest breast cancer diagnosis rate. The increasing disease burden will facilitate higher investments in latest diagnostic technologies. Growing awareness about the condition among younger women will enhance ABUS use. Individuals are becoming more conscious about their age, genetic predisposition, estrogen replacement treatment. A greater number of people are aware about lifestyle variables such as obesity, physical inactivity, eating habits, and alcohol use, that can be the key risk factors for the disease.
The regional market is witnessing an increased focus on the development of innovative and integrated systems that can cater to the individual needs of patients. Advanced ABUS can help healthcare practitioners understand the medical conditions of the patients better, thereby enhancing patient outcomes significantly. In line with consistent efforts to control the disease spread, a rising number of countries have set up various screening programs, aimed at spreading the benefits of diagnosing the condition at an early stage. The implementation of national screening programs in the region is likely to boost industry trends.
The ABUS segment will exceed USD 270 million by 2028, attributed to the higher detection rate of breast cancer when compared to traditional mammography systems. To meet the growing demand for advanced ABUS systems, industry leaders have been involved in R&D and new product launch. Siemens AG’s advanced ACUSON S2000 ABVS represents an innovative ABUS product that offers a 3D total breast ultrasound. It helps identify areas of concern or lesions in dense breast tissues, ensuring a faster and more accurate diagnosis.
Browse detailed statistical insights from the report, “Europe Automated Breast Ultrasound Systems (ABUS) Market Forecast 2028 By End-Use (Hospitals, Diagnostic Imaging Centers), By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), Research Report, Country Outlook (Germany, UK, France, Spain, Italy, Russia, Poland, Ukraine, Switzerland, Belgium, Austria, Czech Republic, Netherlands, Sweden), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
The diagnostic imaging centers segment will surpass USD 360 million by 2028. The availability of advanced healthcare equipment and best-of-class infrastructure of diagnostic centers attracts patients for diagnosis and consultation. With the healthcare spending on cancer treatment for patients across the region growing, the regional market share from these facilities will notice a notable uptick over the upcoming years.
The automated breast ultrasound system in European market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:
Europe Market, By Product
- Automated Breast Ultrasound System (ABUS)
- Automated Breast Volume Scanner (ABVS)
Europe Market, By End-use
- Diagnostic Imaging Centers
The above information has been provided for the following countries:
- Czech Republic